Archivserver der Deutschen Nationalbibliothek

73. Sick P HR, Schuler G. Koronarangioplastie mit beschichteten Stents –
Restenose-Problematik gelöst? . Cardiovasc 2002;
74. Silber S. Cypher versus taxus: are there differences? J Interv Cardiol.
2005; 18:441-6.
75. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi
G, Sousa E, Stoll HP. Sirolimus- vs paclitaxel-eluting stents in de novo
coronary artery lesions: the REALITY trial: a randomized controlled
trial. Jama. 2006; 295:895-904.
76. Stack RS, Califf RM, Phillips HR, Pryor DB, Quigley PJ, Bauman RP,
Tcheng JE, Greenfield JC, Jr. Interventional cardiac catheterization at
Duke Medical Center. Am J Cardiol. 1988; 62:3F-24F.
77. Peng T, Gibula P, Yao KD, Goosen MF. Role of polymers in improving
the results of stenting in coronary arteries. Biomaterials. 1996; 17:685-
94.
78. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg
C. Long-term biocompatibility of a corrodible peripheral iron stent in
the porcine descending aorta. Biomaterials. 2006; 27:4955-62.
79. Bose D, Eggebrecht H, Haude M, Schmermund A, Erbel R. First
absorbable metal stent implantation in human coronary arteries. Am
Heart Hosp J. 2006; 4:128-30.
80. Di Mario C, Griffiths H, Goktekin O, Peeters N, Verbist J, Bosiers M,
Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, Erbel R. Drugeluting
bioabsorbable magnesium stent. J Interv Cardiol. 2004; 17:391-5.
81. Jain R, Shah NH, Malick AW, Rhodes CT. Controlled drug delivery by
biodegradable poly(ester) devices: different preparative approaches.
Drug Dev Ind Pharm. 1998; 24:703-27.
69